title: Hypertonic resuscitation and blood coagulation: in vitro comparison of several hypertonic solutions for their action on platelets and plasma coagulation.
abstract: Resuscitation with hypertonic saline (HS) appears to aggravate bleeding in a model of uncontrolled hemorrhage [J. Trauma 28 (1988) 751; J. Trauma 29 (1989) 79; Arch. Surg. 127 (1992) 93]. This property may be related to the anticoagulant effects of HS on plasma clotting factors and platelets [J. Trauma 31 (1991) 8]. The hypothesis in this study is that a hypertonic solution can be developed that would not disturb the blood coagulation mechanism and could be used as an alternative to hypertonic saline.HS and four different 2400 mosM solutions containing monosaccharides and/or glycine were screened for their in vitro effects on plasma clotting times and platelets. Significant prolongations falling outside the normal range were detected in prothrombin time (PT) and thrombin rime (TT) when only 5% of the volume of normal plasma is HS. Platelet function as measured by extent of shape change (ESC) induced by ADP and aggregation induced by thrombin were also critically impaired by HS at a 5% dilution. All alternative solutions-hypertonic glucose, sorbitol, glycine, glucose/glycine, glucose/mannitol/glycine, sorbitol/glycine-caused a significantly reduced impairment in platelet function and the plasma coagulation system. Hypertonic glycine showed a unique ability to fully preserve the function and integrity of the plasma coagulation system. Considering the pre-deposition of the trauma patient to coagulopathy, administration of HS which clearly is a potent anticoagulant and anti-platelet risks further aggravating the coagulopathy. In contrast, hypertonic glycine preserves the blood coagulation mechanism and exhibits the potential for numerous therapeutic applications. Therefore, prompt evaluation of hypertonic glycine as a resuscitative fluid is highly desirable.
authors.affiliation: Department of Blood Research, Military Casualty Research, Walter Reed Army Research Institute, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA.
authors.forename: Donna M
authors.initials: DM
authors.lastname: Wilder
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Reid
authors.forename: Irina B
authors.initials: IB
authors.lastname: Bakaltcheva
mesh_terms: D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects; D004341:Drug Evaluation; D005998:Glycine / Q000494:pharmacology; D006801:Humans; D006982:Hypertonic Solutions / Q000009:adverse effects* / Q000737:chemistry / Q000592:standards / Q000627:therapeutic use; D009005:Monosaccharides / Q000494:pharmacology; D010949:Plasma / Q000187:drug effects; D015539:Platelet Activation / Q000187:drug effects; D010979:Platelet Function Tests
chemical_list: D006982:Hypertonic Solutions; D009005:Monosaccharides; D005998:Glycine